The global veterinary molecular diagnostics market size is expected to be valued at US$ 194.47 million in 2023, surpassing US$ 377.22 million by 2033. The demand for veterinary molecular diagnostics is projected to grow at a CAGR of 6.84% between 2023 and 2033.
The growth can be attributed to:
Rising Pet Adoption and Animal Health Expenditure to Become Key Trends in the Veterinary Molecular Diagnostics Industry
As of 2022, more than 61% of the United States population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.
The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions. Also, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.
Untapped Emerging Markets to Accelerate the Adoption of Veterinary Molecular Diagnostics
The emerging economies are expected to become a focal point for the growth of the veterinary diagnostics market. The Asia Pacific, Middle Eastern, and Latin American regions are relatively untapped markets for companies compared to Europe and North America.
Large poultry and dairy animal populations in these emerging markets are expected to drive the growth of the veterinary health market. Currently, the number of veterinarians in emerging markets is on the rise.
Emerging countries like India and China have robust livestock markets. According to the Livestock Production Statistics of India 2018, India is one of the largest milk producers (20.17% of the global production), followed by the United States, China, Brazil, and Pakistan.
Further, many veterinary practices are adopting technologically advanced solutions commonly used by veterinarians in developed economies. Thus, with a surge in the companion animal population, growing demand for veterinary services from the livestock industry, and growing companion animal health expenditure, emerging countries across the Asia Pacific and Latin America are expected to offer significant growth opportunities for the market.
High Cost Associated with the Rising Pet Care to Limit the Market Growth
In the last ten years, pet care costs have increased significantly. According to the APPA 2019 report, veterinary care is the second-highest source of spending in the pet care community. The United States, for example, spent over US$ 18.11 billion on veterinary care in 2018, a growth of 6.1% over the previous year. This is expected to reach US$ 19.98 billion in 2019.
Advanced products and procedures play a significant role in treatments. However, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.
| Data Points | Key Statistics |
|---|---|
| Veterinary Molecular Diagnostics Market Value 2023 | US$ 194.47 million |
| Veterinary Molecular Diagnostics Market Projected Value (2033) | US$ 377.22 million |
| Veterinary Molecular Diagnostics Market CAGR (2023 to 2033) | 6.84% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2018, the market represented revenue of US$ 127.69 million. From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 7.3%.
During the historical period of 2018 to 2022, the veterinary molecular diagnostics market experienced steady growth due to the increasing prevalence of zoonotic diseases. Including growing awareness among pet owners about animal health, and advancements in molecular diagnostic techniques. In addition, the rising demand for animal-derived food products and the need for early disease diagnosis in livestock have also contributed to the growth of this market.
The global demand for veterinary molecular diagnostics is projected to increase at a CAGR of 6.84% during the forecast period between 2022 and 2033. The market is anticipated to reach a total of US$ 377.22 million in 2033.
Moving forward, the global veterinary molecular diagnostics market is expected to continue its growth trajectory due to the increasing adoption of pets, the growing awareness about animal health, and the rising prevalence of zoonotic diseases. Additionally, the development of novel molecular diagnostic techniques and the emergence of advanced technologies such as next-generation sequencing is also expected to drive market growth.
The market is expected to face challenges such as the high cost associated with molecular diagnostic tests and the lack of skilled professionals in this field. Nonetheless, the increasing prevalence of zoonotic diseases and the rising demand for early disease diagnosis in animals are expected to be the key drivers of market growth.
The veterinary molecular diagnostics market in the United States is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.
In addition, the presence of major players is one of the major factors contributing to the dominance of the country in the global veterinary molecular diagnostics industry. Moreover, rising awareness about animal wellness and increasing efforts by organizations to promote animal welfare activities in the United States are further promoting the growth of the market in the nation.
The veterinary molecular diagnostics market in Germany is expected to accumulate a market share of 9.5% in 2023. The regional market is expected to continue to maintain the trend over the forecast period as well.
Germany is the second-most lucrative country in the global veterinary molecular diagnostics industry, behind the US. Increased government backing, high-quality diagnostic procedures, and the number of veterinary diagnostic centers are the major factors that are expected to escalate the growth of the veterinary molecular diagnostics industry grow in Germany.
High usage of superior-quality diagnostics techniques and active government support are some other factors that are likely to propel the growth of the veterinary molecular diagnostics industry in Germany during the forecast period.
The veterinary molecular diagnostics market in India is expected to accumulate a market share value of 5% in 2023. India is expected to register significant growth over the forecast period owing to the increase in the number of diagnostic laboratories, government and private funding for veterinary health care activities, and rising awareness about veterinary molecular diagnostics in the region.
In addition, the rapidly rising animal population and high adoption of veterinary diagnostic products within the country are some other factors that are anticipated to fuel the growth of the veterinary molecular diagnostics market in India over the analysis period.
Principal Consultant
PCR Kits are estimated to account for the largest market share of 50.8% of the veterinary molecular diagnostics industry in 2023. Polymerase Chain Reaction (PCR) is widely used for molecular diagnosis in animals for the identification and detection of various pathogens. Traditional PCR techniques are rapidly being replaced by real-time PCR.
The PCR kits segment is driving the market growth, owing to factors such as the increasing need for quick result-generating tests, growing research studies for the development of new DNA and RNA-based therapies, and others.
In addition, the increasing adulteration of food products and the growing need for accurate diagnosis are some other factors that are expected to fuel the growth of the PCR Kits segment of the veterinary molecular diagnostics market in the forthcoming years.
Based on the species type, the livestock animals segment is expected to witness a significant growth of 71.0% in 2023. This growth is attributed to the rising number of companion animals across the globe. The sales are also propelled by the willingness of owners to spend more on their pets, the rising adoption of pet insurance, and the availability of cheaper and easy-to-use POC diagnostic tests for companion animals.
Moreover, infectious diseases cause a loss of production capacity in livestock animals. Therefore, governments across the globe are heavily focusing on increasing awareness about these diseases by undertaking initiatives related to diagnosis. Also, governments are working with domestic and international partners to promote animal health products. These initiatives help educate decision-makers, regulatory agencies, reference laboratories, and other end-users regarding the importance of livestock diagnosis.
Startups in the veterinary molecular diagnostics industry such as Basepaws, Embark Veterinary, and AnimalBiome are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and creating a larger customer base. For instance,
Basepaws is a cat genetic testing company that was established in 2018. The client must collect a sample of the cat hair and ship it to the business's laboratory for sequencing to use the service. The business examines the DNA sequence and produces a report that details the genetic composition (mix of varieties). The business utilizes genetic information to build a cross-species library of genotypic and phenotypic information that will probably be used to support translational research and comparative medicine.
Embark Veterinary, which was founded in 2015, offers DNA test kits for dogs that help dog owners provide their pets with better care. More than 200,000 genetic markers are tracked by the test. Also, it offers dog owners an app via which they can schedule a visit from the Embark team and learn more about the test kit.
AnimalBiome is a supplier of diagnostic services based on the animal microbiome for the care of pets. Customers can send samples through an evaluation kit to extract and analyze DNA to understand the gut microbiota of their pets. They deliver an analysis report that also has a tool for comparing gut health and flags any unusual patterns in the data.
Who are the Leading Players in the Veterinary Molecular Diagnostics Market?
The veterinary molecular diagnostics industry is highly competitive, with several key players dominating the market. Companies such as IDEXX Laboratories, VCA Antech, Zoetis, and Thermo Fisher Scientific hold a significant market share and are continuously innovating to maintain their positions. Smaller players in the market are also making their mark by developing niche solutions to cater to specific veterinary needs.
One of the main challenges faced by companies in the veterinary molecular diagnostics industry is the high cost associated with developing and launching new diagnostic solutions. Additionally, strict regulations and approval processes by regulatory bodies such as the FDA and USDA can pose a challenge for companies looking to enter the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The growing demand for molecular diagnostic solutions for pets and livestock presents a significant investment opportunity for new entrants in the market. The rise in pet ownership and increasing awareness regarding animal health has led to a surge in demand for innovative diagnostic solutions. Companies focusing on developing cost-effective, accurate, and user-friendly diagnostic tools for veterinarians can potentially carve out a niche for themselves in the market. Furthermore, strategic collaborations and partnerships with established players can help new entrants gain a foothold in the competitive landscape.
Recent Developments:
How Companies can Scale Their Businesses in the Veterinary Molecular Diagnostics Market?
Businesses can increase their foothold in the market by investing in research and development to develop innovative products that can meet the growing demand for more accurate and efficient diagnostic tests. This can include developing new tests that can detect a wider range of diseases or improving existing tests to provide faster and more reliable results.
Companies can also scale their businesses by forming strategic partnerships with other companies in the industry. This can include partnering with biotech companies to develop new products or with veterinary clinics to expand their customer base.
Companies can also scale their businesses by expanding into emerging markets where there is a growing demand for veterinary diagnostic tests. This can include countries in Asia, Latin America, and Africa where the demand for animal products is rising due to population growth and increasing urbanization. By expanding into these markets, companies can tap into new sources of revenue and gain a competitive advantage over their rivals.
Businesses can also expand by adopting digital technologies such as telemedicine and remote monitoring. This can enable companies to provide more convenient and cost-effective diagnostic services to their customers, while also improving the accuracy and speed of their tests. By embracing these technologies, companies can stay ahead of the curve and position themselves as leaders in the industry.
Finally, companies can scale their businesses by investing in talent and training to attract and retain the best employees in the industry. This can include providing ongoing training and development opportunities to ensure that employees are up-to-date on the latest developments in the field. By investing in talent and training, companies can build a strong and skilled workforce that can help them grow and innovate in the Veterinary Molecular Diagnostics market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.84% from 2023 to 2033 |
| Market Value in 2022 | US$ 194.47 million |
| Market Value in 2033 | US$ 377.22 million |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The market is valued at US$ 194.47 million in 2023.
IDEXX Laboratories and Thermo Fisher Scientific Inc. are key market players.
The livestock animals segment is likely to remain preferred through 2033.
Players opt for mergers and acquisitions.
India, Japan, and China dominate the Asian market.
1. Executive Summary | Veterinary Molecular Diagnostics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. PCR Kits
5.3.1.1. RT-PCR Kits
5.3.1.2. RAPD-PCR Kits
5.3.2. INAAT Kits
5.3.3. Microarray Kits
5.3.4. DNA Sequencing Kits
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Disease, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease, 2023 to 2033
6.3.1. Anaplasma spp.
6.3.2. Ehrlichia spp.
6.3.3. New Castle Disease
6.3.4. Influenza
6.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Disease, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Species, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Species, 2023 to 2033
7.3.1. Livestock Animals
7.3.1.1. Porcine
7.3.1.2. Poultry
7.3.1.3. Bovine/Cattle
7.3.1.4. Aquatic
7.3.1.5. Ovine
7.3.2. Companion Animals
7.3.2.1. Canine
7.3.2.2. Feline
7.3.2.3. Avian
7.4. Y-o-Y Growth Trend Analysis By Species, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Species, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Veterinary Hospitals
8.3.2. Clinical Laboratories
8.3.3. Veterinary Research Institutes
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Disease
10.2.4. By Species
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Disease
10.3.4. By Species
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Disease
11.2.4. By Species
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Disease
11.3.4. By Species
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UNITED KINGDOM
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product
12.2.3. By Disease
12.2.4. By Species
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Disease
12.3.4. By Species
12.3.5. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Product
13.2.3. By Disease
13.2.4. By Species
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Disease
13.3.4. By Species
13.3.5. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Disease
14.2.4. By Species
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Disease
14.3.4. By Species
14.3.5. By End User
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Product
15.2.3. By Disease
15.2.4. By Species
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Disease
15.3.4. By Species
15.3.5. By End User
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product
16.2.3. By Disease
16.2.4. By Species
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Disease
16.3.4. By Species
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Disease
17.1.2.3. By Species
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Disease
17.2.2.3. By Species
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Disease
17.3.2.3. By Species
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Disease
17.4.2.3. By Species
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Disease
17.5.2.3. By Species
17.5.2.4. By End User
17.6. UNITED KINGDOM
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Disease
17.6.2.3. By Species
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Disease
17.7.2.3. By Species
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Disease
17.8.2.3. By Species
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Disease
17.9.2.3. By Species
17.9.2.4. By End User
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Disease
17.10.2.3. By Species
17.10.2.4. By End User
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Disease
17.11.2.3. By Species
17.11.2.4. By End User
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Disease
17.12.2.3. By Species
17.12.2.4. By End User
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Disease
17.13.2.3. By Species
17.13.2.4. By End User
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Disease
17.14.2.3. By Species
17.14.2.4. By End User
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Disease
17.15.2.3. By Species
17.15.2.4. By End User
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product
17.16.2.2. By Disease
17.16.2.3. By Species
17.16.2.4. By End User
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product
17.17.2.2. By Disease
17.17.2.3. By Species
17.17.2.4. By End User
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product
17.18.2.2. By Disease
17.18.2.3. By Species
17.18.2.4. By End User
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product
17.19.2.2. By Disease
17.19.2.3. By Species
17.19.2.4. By End User
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product
17.20.2.2. By Disease
17.20.2.3. By Species
17.20.2.4. By End User
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product
17.21.2.2. By Disease
17.21.2.3. By Species
17.21.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Disease
18.3.4. By Species
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. bioMérieux SA
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. IDEXX Laboratories, Inc.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Neogen Europe, Ltd.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Veterinary Molecular Diagnostics, Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Thermo Fisher Scientific, Inc.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Qiagen N.V.
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Zoetis
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Heska Corp.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Agrolabo S.p.A.
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Covetrus
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Veterinary Molecular Diagnostics Market
